TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 17, 1996
Grant Date -
N/A
app pub date -
Oct 13, 1994
filing date -
Oct 13, 1994
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Technetium or rhenium radionuclide labelled chelate-hexapeptide complexes are useful for the selective detection or treatment of tumors with somatostatin receptors. In particular, compounds of formula: ##STR1## (wherein R, R.sup.1, R.sup.3 and A are as defined herein) incorporating an N3S2 chelate may be labelled with a radionuclide. The resulting complexes are useful as radioimaging agents or as radiopharmaceuticals for the treatment of certain tumors.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully